Skip to main content
TipRanks
Go Ultimate75% OFF

Globus Medical (GMED) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

GMED Analyst Ratings

Moderate Buy
10Ratings
6Buy4Hold0Sell
Based on 10 analysts giving stock ratings to Globus Medical in the past 3 months

GMED Stock 12 Month Forecast

Mex$1,691â–²(9.13% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is MXN 1,691.44 with a high forecast of MXN 1,946.32 and a low forecast of MXN 1,445.84. The average price target represents a 9.13% change from the last price of MXN 1,550.00.
Highest Price TargetMex$1,946Average Price TargetMex$1,691Lowest Price TargetMex$1,446

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:GMED
Price TargetArticle
BMO CapitalMex$1,742→Mex$1,446hold-6.72%DownsideDowngraded11/06/26
Wells FargoMex$1,835→Mex$1,854buy19.59%UpsideAssigned11/06/26
Piper SandlerMex$1,854buy19.59%UpsideReiterated11/06/26
Canaccord GenuityMex$2,132→Mex$1,946buy25.57%UpsideReiterated11/06/26
Truist FinancialMex$1,854→Mex$1,668buy7.63%UpsideReiterated11/06/26
Bank of America Securities―buy―Reiterated11/06/26
RBC CapitalMex$1,576buy1.65%UpsideReiterated11/05/26
Stifel NicolausMex$1,417→Mex$1,576hold1.65%UpsideReiterated10/07/26
BTIG―hold―Reiterated09/18/26
Freedom Capital MarketsMex$1,613hold4.04%UpsideReiterated08/27/26
NeedhamMex$2,169buy39.92%UpsideReiterated08/07/26
TD CowenMex$2,132buy37.53%UpsideReiterated08/06/26
UBSMex$1,520hold-1.94%DownsideInitiated07/28/26
BarclaysMex$2,280buy47.10%UpsideReiterated05/11/26
JefferiesMex$1,946→Mex$2,132buy37.53%UpsideReiterated01/08/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

3 Months
Matt Miksic
Matt MiksicBarclays
Success Rate16/32 ratings generated profit
50%
Average Return
+1.98%

Copying Matt Miksic's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +1.98% per trade.

1 Year
Matt Miksic
Matt MiksicBarclays
Success Rate19/32 ratings generated profit
59%
Average Return
+11.61%

Copying Matt Miksic's trades and holding each position for 1 Year would result in 59.38% of your transactions generating a profit, with an average return of +11.61% per trade.

2 Years
Matt Miksic
Matt MiksicBarclays
Success Rate22/32 ratings generated profit
69%
Average Return
+18.38%

Copying Matt Miksic's trades and holding each position for 2 Years would result in 68.75% of your transactions generating a profit, with an average return of +18.38% per trade.

GMED Analyst Recommendation Trends

010203040Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for GMED
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy20000
Buy121815137
Hold58863
Sell00000
Strong Sell00000
total1926231910

In the current month, GMED has received 7 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. GMED average Analyst price target in the past 3 months is 1,691.44.

GMED Financial Forecast

Mex$19Mex$20.5Mex$22Mex$23.5Mex$25Q1 2026Q3 2026Q4 2026
HighMex$24.55
ConsensusMex$23.98
LowMex$22.88

GMED Earnings Forecast

Next quarter’s earnings estimate for GMED is MXN 23.98 with a range of MXN 22.88 to MXN 24.55. The previous quarter’s EPS was MXN 22.88. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

Mex$14.1BMex$14.6BMex$15BMex$15.4BMex$15.9BQ1 2026Q3 2026Q4 2026
HighMex$15.9B
ConsensusMex$14.6B
LowMex$14.4B

GMED Sales Forecast

Next quarter’s sales forecast for GMED is MXN 14.57B with a range of MXN 14.38B to MXN 15.88B. The previous quarter’s sales results were MXN 14.21B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

GMED Stock Forecast FAQ

What is MX:GMED’s average 12-month price target, according to analysts?
Based on analyst ratings, Globus Medical’s 12-month average price target is Mex$1,691.44.
What is MX:GMED’s upside potential, based on the analysts’ average price target?
Globus Medical has 9.13% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Globus Medical a Buy, Sell or Hold?
Globus Medical has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 0 sell ratings.
What is Globus Medical’s share price target?
The average share price target for Globus Medical is Mex$1,691.44. This is based on 10 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$1,946.32, and the lowest forecast is Mex$1,445.84. The average share price target represents a 9.13% increase from the current price of Mex$1,550.
What do analysts say about Globus Medical?
Globus Medical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Street analysts.
How can I buy shares of Globus Medical?
To buy shares of MX:GMED, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.